UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Adiposity and plasma concentrations of kynurenine pathway metabolites and traditional markers of inflammation

Wang, Mengmei E; Hodge, Allison M; Li, Sherly X; Southey, Melissa C; Giles, Graham G; Dugué, Pierre-Antoine; (2023) Adiposity and plasma concentrations of kynurenine pathway metabolites and traditional markers of inflammation. Obesity Research & Clinical Practice , 17 (3) pp. 203-209. 10.1016/j.orcp.2023.04.004. Green open access

[thumbnail of Wang_Adiposity and plasma concentrations of kynurenine pathway metabolites and traditional markers of inflammation_AAM.pdf]
Preview
Text
Wang_Adiposity and plasma concentrations of kynurenine pathway metabolites and traditional markers of inflammation_AAM.pdf

Download (592kB) | Preview

Abstract

AIM: The kynurenine pathway is increasingly recognised to play a role in inflammation and disease. We assessed the cross-sectional and longitudinal associations of adiposity measures (body mass index, waist-hip ratio, waist circumference and fat mass ratio) with plasma concentrations of kynurenine pathway metabolites and traditional markers of inflammation. METHODS: We used data from 970 Melbourne Collaborative Cohort Study participants who had plasma markers measured at baseline (median age 59 years) and follow-up (median age 70 years). Linear regression was used to assess cross-sectional and longitudinal associations between four adiposity measures and concentrations of i) nine kynurenine pathway metabolites; ii) two derived markers; iii) eight traditional inflammatory markers. RESULTS: Cross-sectionally, most kynurenine metabolites were strongly associated with adiposity measures at both time points; associations were generally stronger than for most inflammation markers except CRP (e.g. body mass index at baseline, quinolinic acid (per S.D. β = 0.30, 95%CI: 0.24–0.36, P = 10−21), kynurenine (β = 0.25, 95%CI: 0.19–0.31, P = 10−16) and CRP (β = 0.31, 95%CI: 0.25–0.37, P = 10−24), and remained largely unchanged after adjustment for confounders. Longitudinally, changes in adiposity measures over approximately a decade were positively associated with changes in kynurenine metabolite concentrations (in particular for 3-hydroxyanthranilic acid, kynurenine and quinolinic acid), and more strongly so than for other markers of inflammation, including CRP. CONCLUSIONS: In middle-aged and older adults, plasma concentrations of kynurenine metabolites are strongly associated with adiposity, both cross-sectionally and longitudinally. Our study demonstrates that kynurenine metabolites may be valuable markers to monitor the adverse consequences of obesity.

Type: Article
Title: Adiposity and plasma concentrations of kynurenine pathway metabolites and traditional markers of inflammation
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.orcp.2023.04.004
Publisher version: https://doi.org/10.1016/j.orcp.2023.04.004
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
Keywords: Inflammation, Tryptophan kynurenine pathway, Body composition, Body size, Aging
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health
URI: https://discovery.ucl.ac.uk/id/eprint/10179101
Downloads since deposit
20Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item